http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020055857-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aee6577ef55a630cc43920d866a40dfd |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-431 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D477-20 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D477-20 |
filingDate | 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7904b0e28a6098cda8ebb61042e4327b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_458f8ab3d3b6a03ba19ab4322b2bacf4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88a69b5cb7487ca408072002add08887 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_739d892bc8a9ffbec0a9ab3c6a3e28c1 |
publicationDate | 2020-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2020055857-A1 |
titleOfInvention | Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use |
abstract | The disclosure is directed to new crystalline tebipenem pivoxil salt forms, including a crystalline tebipenem pivoxil ethane sulfonate salt form (Form A), a crystalline tebipenem pivoxil ketoglutarate salt form (Form A), tebipenem pivoxil maleate salt forms (Form A and Form B), a tebipenem pivoxil malate salt form (Form A), a tebipenem pivoxil methane sulfonate salt form (Form B), a tebipenem pivoxil hydrobromide salt form (Form B), and a tebipenem pivoxil edisylate salt form (Form A). The disclosure also includes a composition, comprising a crystalline tebipenem pivoxil salt and a pharmaceutically acceptable carrier and further includes a method for treating an antibiotic resistant bacterial infection, comprising administering to a patient in need of such treatment a therapeutically effective amount of a crystalline tebipenem pivoxil salt. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022104087-A1 |
priorityDate | 2017-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 127.